Zhengye Biotechnology (NASDAQ:ZYBT) Shares Down 4.8% – Here’s What Happened

Posted by Stanley Muller on Aug 12th, 2026

Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT – Get Free Report) fell 4.8% during mid-day trading on Monday . The company traded as low as $1.77 and last traded at $1.80. 443,959 shares traded hands during mid-day trading, a decline of 97% from the average session volume of 16,103,109 shares. The stock had previously closed at $1.89.

Analysts Set New Price Targets

Separately, Weiss Ratings raised shares of Zhengye Biotechnology from a “sell (d-)” rating to a “sell (d)” rating in a research report on Monday, July 20th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock currently has an average rating of “Sell”.

Get Our Latest Research Report on Zhengye Biotechnology

Zhengye Biotechnology Trading Down 3.7%

The company has a quick ratio of 0.82, a current ratio of 1.14 and a debt-to-equity ratio of 0.03. The business’s 50 day moving average is $1.20 and its 200-day moving average is $1.01.

Institutional Investors Weigh In On Zhengye Biotechnology

Hedge funds and other institutional investors have recently made changes to their positions in the business. Citadel Advisors LLC acquired a new position in shares of Zhengye Biotechnology during the 3rd quarter worth about $31,000. Millennium Management LLC acquired a new stake in Zhengye Biotechnology in the 3rd quarter valued at approximately $38,000. WINTON GROUP Ltd acquired a new stake in Zhengye Biotechnology in the 3rd quarter valued at approximately $56,000. XTX Topco Ltd increased its position in Zhengye Biotechnology by 71.4% in the 4th quarter. XTX Topco Ltd now owns 59,286 shares of the company’s stock worth $68,000 after buying an additional 24,697 shares during the period. Finally, Geode Capital Management LLC bought a new position in Zhengye Biotechnology in the 2nd quarter worth approximately $174,000.

About Zhengye Biotechnology

(Get Free Report)

Zhengye Biotechnology Holding Limited is a veterinary vaccine manufacturer which encompasses research, development, manufacturing and sales of veterinary vaccines, with a focus on livestock vaccine principally in China. Zhengye Biotechnology Holding Limited is based in Jilin, China.